美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Skye Bioscience Inc.

0.6490

-0.0062-0.95%

盘后：0.6344-0.0146-2.25%17:12 EDT

成交量：27.69万

成交额：17.93万

市值：2,166.28万

市盈率：-0.46

高：0.6600

开：0.6600

低：0.6337

收：0.6552

52周最高：5.75

52周最低：0.6100

股本：3,337.88万

流通股本：1,988.22万

量比：1.04

换手率：1.39%

股息：- -

股息率：- -

每股收益(TTM):-1.4100

每股收益(LYR):-1.4100

净资产收益率：-126.85%

总资产收益率：-71.93%

市净率：1.08

市盈率(LYR):-0.46

数据加载中...

总览公司新闻资讯公告

Skye Bioscience, Inc.盘中异动早盘股价大涨7.52%

Skye公布Nimacimab联合司美格鲁肽Cbeyond二期a阶段扩展研究积极中期结果

Skye Bioscience Inc. 联合疗法52周减重22.3%：Nimacimab联合司美格鲁肽（2.4毫克）展现显著成效

BUZZ-与 Halozyme 合作开发肥胖症药物，Skye 生物科学公司业绩攀升

Skye Bioscience Inc.计划于2026年年中启动Nimacimab联合Enhanze技术治疗肥胖症的2B期临床试验

奥洛兹美医疗与Skye Bioscience达成全球合作与许可协议，共同评估Nimacimab与Enhanze®复方制剂用于肥胖症治疗

Skye Bioscience, Inc.盘中异动股价大跌5.13%报0.740美元

Skye Bioscience, Inc.盘中异动股价大跌5.17%

Skye Bioscience, Inc.盘中异动快速下挫5.34%报1.24美元

Skye Bioscience, Inc.盘中异动早盘快速上涨6.85%报1.56美元

Skye Bioscience, Inc.盘中异动早盘股价大涨5.52%

Skye Bioscience, Inc.盘中异动早盘股价大涨5.26%报1.40美元

BUZZ-减肥药物中期研究未达主要目标，斯凯公司股价暴跌

斯凯生物科学公司的肥胖症药物未能达到中期研究的主要目标

Skye Bioscience公布Cbeyond™ 2a期临床试验顶级数据，涵盖Nimacimab单药治疗和联合治疗方案

BUZZ-H.C. Wainwright 给予 Skye Bioscience "买入 "评级

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SKYE/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SKYE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SKYE\",,,,,undefined,":{"symbol":"SKYE","market":"US","secType":"STK","nameCN":"Skye Bioscience Inc.","latestPrice":0.649,"timestamp":1774036800000,"preClose":0.6552,"halted":0,"volume":276899,"hourTrading":{"tag":"盘后","latestPrice":0.6344,"preClose":0.649,"latestTime":"17:12 EDT","volume":14471,"amount":9332.5099752,"timestamp":1774041161076,"change":-0.0146,"changeRate":-0.022496,"amplitude":0.023729},"delay":0,"changeRate":-0.009462759462759438,"floatShares":19882200,"shares":33378764,"eps":-1.410011,"marketStatus":"盘后交易","change":-0.0062,"latestTime":"03-20 17:32:48 EDT","open":0.66,"high":0.66,"low":0.6337,"amount":179256.11670595998,"amplitude":0.04014,"askPrice":0.6774,"askSize":2,"bidPrice":0.63,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-1.410011,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774051200000},"marketStatusCode":4,"symbolChange":{"newSymbol":"SKYED","executeDate":"2023-09-08"},"adr":0,"exchange":"NASDAQ","adjPreClose":0.6552,"preHourTrading":{"tag":"盘前","latestPrice":0.6551,"preClose":0.6552,"latestTime":"09:20 EDT","volume":1522,"amount":990.9031226,"timestamp":1774012849995,"change":-0.0001,"changeRate":-0.000153,"amplitude":0.023199},"postHourTrading":{"tag":"盘后","latestPrice":0.6344,"preClose":0.649,"latestTime":"17:12 EDT","volume":14471,"amount":9332.5099752,"timestamp":1774041161076,"change":-0.0146,"changeRate":-0.022496,"amplitude":0.023729},"volumeRatio":1.043048,"impliedVol":1.1162,"impliedVolPercentile":0.3904},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SKYE\",,,,,undefined,":{"symbol":"SKYE","floatShares":19882200,"roa":"-71.93%","roe":"-126.85%","lyrEps":-1.410011,"volumeRatio":1.043048,"shares":33378764,"dividePrice":0,"high":0.66,"amplitude":0.04014,"preClose":0.6552,"low":0.6337,"week52Low":0.61,"pbRate":"1.08","week52High":5.75,"institutionHeld":0,"latestPrice":0.649,"committee":0.2,"eps":-1.410011,"divideRate":0,"volume":276899,"delay":0,"ttmEps":-1.410011,"open":0.66,"prevYearClose":0.7497,"prevWeekClose":0.6603,"prevMonthClose":0.7449,"prevQuarterClose":0.7497,"fiveDayClose":0.6603,"twentyDayClose":0.7815,"sixtyDayClose":0.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SKYE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-10","symbol":"SKYE","fiscalQuarterEnding":"2025/12","expectedEps":-0.29,"name":null,"time":"盘后","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2025-11-10","symbol":"SKYE","fiscalQuarterEnding":"2025/09","expectedEps":-0.33,"name":null,"time":"盘后","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.32},{"market":"US","date":"2025-08-07","symbol":"SKYE","fiscalQuarterEnding":"2025/06","expectedEps":-0.34,"name":null,"time":"盘后","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.44},{"market":"US","date":"2025-05-08","symbol":"SKYE","fiscalQuarterEnding":"2025/03","expectedEps":-0.31,"name":null,"time":"盘后","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2025-03-20","symbol":"SKYE","fiscalQuarterEnding":"2024/12","expectedEps":-0.3,"name":null,"time":"盘后","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"post","actualEps":-0.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SKYE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SKYE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.625,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1759809600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SKYE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SKYE","date":"2026-03-19","current":-0.459287,"percent":0.995726,"low":-12.94129,"twenty":-4.568894,"median":-3.077727,"eighty":-1.060422,"high":-0.3941,"avg":-3.471331,"sd":2.574853,"marketCap":22470583},"quantilePoints":[{"date":"2024-04-12","current":-9.459964,"twenty":-9.513638,"median":-9.459964,"eighty":-7.885539,"marketCap":356118289},{"date":"2024-04-19","current":-12.650558,"twenty":-12.435864,"median":-9.657512,"eighty":-9.495746,"marketCap":476227531},{"date":"2024-04-26","current":-9.579238,"twenty":-12.081022,"median":-9.691058,"eighty":-9.561347,"marketCap":360608354},{"date":"2024-05-03","current":-9.683603,"twenty":-11.635233,"median":-9.68733,"eighty":-9.561347,"marketCap":364537161},{"date":"2024-05-10","current":-8.997775,"twenty":-10.807766,"median":-9.638876,"eighty":-9.507673,"marketCap":338719287},{"date":"2024-05-17","current":-9.168,"twenty":-10.15772,"median":-9.601602,"eighty":-9.22813,"marketCap":343770610},{"date":"2024-05-24","current":-8.952556,"twenty":-9.700003,"median":-9.54942,"eighty":-8.9931,"marketCap":335692167},{"date":"2024-05-31","current":-8.720508,"twenty":-9.691058,"median":-9.489815,"eighty":-8.983995,"marketCap":326991116},{"date":"2024-06-07","current":-8.47349,"twenty":-9.691058,"median":-9.389145,"eighty":-8.952556,"marketCap":317728707},{"date":"2024-06-14","current":-8.069277,"twenty":-9.691058,"median":-9.18753,"eighty":-8.690567,"marketCap":302572037},{"date":"2024-06-21","current":-6.684476,"twenty":-9.685094,"median":-9.060284,"eighty":-8.473188,"marketCap":250646409},{"date":"2024-06-28","current":-5.434411,"twenty":-9.674658,"median":-9.022864,"eighty":-8.245631,"marketCap":203773004},{"date":"2024-07-05","current":-5.58412,"twenty":-9.638876,"median":-8.993879,"eighty":-7.844715,"marketCap":209386586},{"date":"2024-07-12","current":-4.873005,"twenty":-9.631421,"median":-8.980898,"eighty":-7.11863,"marketCap":182722074},{"date":"2024-07-15","current":-4.820607,"twenty":-9.62993,"median":-8.974213,"eighty":-6.892464,"marketCap":180757321},{"date":"2024-08-02","current":-4.102007,"twenty":-9.628439,"median":-8.967527,"eighty":-6.745055,"marketCap":153812130},{"date":"2024-08-09","current":-3.735222,"twenty":-9.606075,"median":-8.870216,"eighty":-5.58412,"marketCap":140058855},{"date":"2024-08-16","current":-3.615791,"twenty":-9.579238,"median":-8.690567,"eighty":-4.690361,"marketCap":152904981},{"date":"2024-08-23","current":-3.787972,"twenty":-9.567311,"median":-8.506414,"eighty":-4.17237,"marketCap":160186171},{"date":"2024-08-30","current":-4.584307,"twenty":-9.543456,"median":-8.189044,"eighty":-4.185844,"marketCap":193861673},{"date":"2024-09-06","current":-4.347559,"twenty":-9.525571,"median":-8.069277,"eighty":-4.204574,"marketCap":183850037},{"date":"2024-09-13","current":-4.304513,"twenty":-9.489808,"median":-7.545298,"eighty":-4.204574,"marketCap":182029740},{"date":"2024-09-20","current":-3.93863,"twenty":-9.483818,"median":-7.11863,"eighty":-4.170873,"marketCap":166557212},{"date":"2024-09-27","current":-2.840979,"twenty":-9.431636,"median":-6.35886,"eighty":-4.072065,"marketCap":120139628},{"date":"2024-10-04","current":-2.56836,"twenty":-9.296072,"median":-5.58412,"eighty":-3.802872,"marketCap":108611078},{"date":"2024-10-11","current":-2.683147,"twenty":-9.199248,"median":-5.224584,"eighty":-3.740033,"marketCap":113465204},{"date":"2024-10-18","current":-3.034682,"twenty":-9.153032,"median":-4.873005,"eighty":-3.308736,"marketCap":128330966},{"date":"2024-10-25","current":-3.501004,"twenty":-9.080009,"median":-4.593919,"eighty":-3.325954,"marketCap":148050855},{"date":"2024-10-31","current":-3.651662,"twenty":-9.02741,"median":-4.557114,"eighty":-3.343172,"marketCap":154421896},{"date":"2024-11-08","current":-7.770049,"twenty":-9.018318,"median":-4.55561,"eighty":-3.379043,"marketCap":165040297},{"date":"2024-11-15","current":-7.870031,"twenty":-8.997775,"median":-4.571462,"eighty":-3.501004,"marketCap":167163977},{"date":"2024-11-22","current":-5.956085,"twenty":-8.989983,"median":-4.820607,"eighty":-3.501004,"marketCap":126510669},{"date":"2024-11-29","current":-6.413147,"twenty":-8.983995,"median":-4.921494,"eighty":-3.53544,"marketCap":136218922},{"date":"2024-12-06","current":-5.070528,"twenty":-8.981218,"median":-5.25247,"eighty":-3.595703,"marketCap":107700929},{"date":"2024-12-13","current":-4.784865,"twenty":-8.970201,"median":-5.21336,"eighty":-3.614356,"marketCap":101633271},{"date":"2024-12-20","current":-4.084989,"twenty":-8.95555,"median":-5.042643,"eighty":-3.644488,"marketCap":86767509},{"date":"2024-12-27","current":-3.799325,"twenty":-8.952556,"median":-4.89725,"eighty":-3.64221,"marketCap":80699851},{"date":"2025-01-03","current":-4.070706,"twenty":-8.886684,"median":-4.82416,"eighty":-3.64221,"marketCap":86464126},{"date":"2025-01-10","current":-4.427785,"twenty":-8.774403,"median":-4.734873,"eighty":-3.64221,"marketCap":94048699},{"date":"2025-01-17","current":-3.856458,"twenty":-8.71452,"median":-4.60353,"eighty":-3.6441,"marketCap":81913383},{"date":"2025-01-24","current":-3.727909,"twenty":-8.690567,"median":-4.558618,"eighty":-3.651662,"marketCap":79182936},{"date":"2025-01-31","current":-5.356192,"twenty":-8.660625,"median":-4.557114,"eighty":-3.694707,"marketCap":113768587},{"date":"2025-02-07","current":-4.256387,"twenty":-8.539337,"median":-4.55561,"eighty":-3.699343,"marketCap":90408104},{"date":"2025-02-14","current":-4.370652,"twenty":-8.47349,"median":-4.466458,"eighty":-3.699343,"marketCap":92835167},{"date":"2025-02-21","current":-4.470635,"twenty":-8.472282,"median":-4.477777,"eighty":-3.722196,"marketCap":94958847},{"date":"2025-02-28","current":-3.827892,"twenty":-8.245631,"median":-4.442068,"eighty":-3.730044,"marketCap":81306617},{"date":"2025-03-07","current":-3.670777,"twenty":-8.162365,"median":-4.40636,"eighty":-3.699343,"marketCap":77969405},{"date":"2025-03-14","current":-3.463671,"twenty":-8.134468,"median":-4.354733,"eighty":-3.698416,"marketCap":73570353},{"date":"2025-03-21","current":-2.203547,"twenty":-8.081254,"median":-4.304513,"eighty":-3.649772,"marketCap":58541914},{"date":"2025-03-28","current":-2.471704,"twenty":-7.90988,"median":-4.297339,"eighty":-3.6255,"marketCap":65666062},{"date":"2025-04-04","current":-1.632257,"twenty":-7.858605,"median":-4.256387,"eighty":-3.582221,"marketCap":43364381},{"date":"2025-04-11","current":-1.562303,"twenty":-7.846922,"median":-4.225597,"eighty":-3.501004,"marketCap":41505907},{"date":"2025-04-17","current":-1.842119,"twenty":-7.799915,"median":-4.189726,"eighty":-3.364695,"marketCap":48939801},{"date":"2025-04-25","current":-2.086958,"twenty":-7.727199,"median":-4.165203,"eighty":-3.259602,"marketCap":55444458},{"date":"2025-05-02","current":-2.366773,"twenty":-7.630073,"median":-4.156405,"eighty":-3.056205,"marketCap":62878352},{"date":"2025-05-09","current":-1.698098,"twenty":-7.560926,"median":-4.127838,"eighty":-2.911286,"marketCap":55444458},{"date":"2025-05-16","current":-1.907406,"twenty":-7.545298,"median":-4.116978,"eighty":-2.799369,"marketCap":62278559},{"date":"2025-05-23","current":-1.964344,"twenty":-7.500386,"median":-4.077848,"eighty":-2.746856,"marketCap":64137621},{"date":"2025-05-30","current":-2.011792,"twenty":-7.329718,"median":-4.070706,"eighty":-2.683147,"marketCap":65686838},{"date":"2025-06-06","current":-2.040261,"twenty":-7.099247,"median":-4.06458,"eighty":-2.616276,"marketCap":66616369},{"date":"2025-06-13","current":-2.05924,"twenty":-6.976473,"median":-4.013573,"eighty":-2.54373,"marketCap":67236056},{"date":"2025-06-20","current":-2.030771,"twenty":-6.805634,"median":-3.979786,"eighty":-2.387759,"marketCap":66306526},{"date":"2025-06-27","current":-4.033073,"twenty":-6.650207,"median":-3.970723,"eighty":-2.387759,"marketCap":131683521},{"date":"2025-07-03","current":-4.374698,"twenty":-6.513129,"median":-3.970723,"eighty":-2.471704,"marketCap":142837890},{"date":"2025-07-11","current":-3.738896,"twenty":-6.413147,"median":-3.970723,"eighty":-2.503792,"marketCap":122078370},{"date":"2025-07-18","current":-3.530125,"twenty":-6.413147,"median":-3.966646,"eighty":-2.541658,"marketCap":115261811},{"date":"2025-07-25","current":-3.805323,"twenty":-6.298881,"median":-3.947535,"eighty":-2.546837,"marketCap":124247275},{"date":"2025-08-01","current":-3.387782,"twenty":-6.198899,"median":-3.902759,"eighty":-2.561185,"marketCap":110614158},{"date":"2025-08-08","current":-3.368802,"twenty":-6.1132,"median":-3.885025,"eighty":-2.56836,"marketCap":109994470},{"date":"2025-08-15","current":-2.391434,"twenty":-6.1132,"median":-3.856458,"eighty":-2.546837,"marketCap":101332133},{"date":"2025-08-22","current":-2.596205,"twenty":-6.1132,"median":-3.856458,"eighty":-2.541658,"marketCap":110008891},{"date":"2025-08-29","current":-2.545012,"twenty":-6.033244,"median":-3.838191,"eighty":-2.530385,"marketCap":107839701},{"date":"2025-09-05","current":-2.74247,"twenty":-6.003302,"median":-3.805323,"eighty":-2.498872,"marketCap":116206575},{"date":"2025-09-12","current":-3.115445,"twenty":-5.964031,"median":-3.793648,"eighty":-2.525066,"marketCap":132010669},{"date":"2025-09-19","current":-2.881421,"twenty":-5.898952,"median":-3.776855,"eighty":-2.539403,"marketCap":122094374},{"date":"2025-09-26","current":-2.632771,"twenty":-5.861816,"median":-3.757875,"eighty":-2.544341,"marketCap":111558312},{"date":"2025-10-03","current":-3.28365,"twenty":-5.684705,"median":-3.738896,"eighty":-2.546472,"marketCap":139138005},{"date":"2025-10-10","current":-1.257879,"twenty":-5.595667,"median":-3.729992,"eighty":-2.525066,"marketCap":53300082},{"date":"2025-10-17","current":-1.060422,"twenty":-5.58412,"median":-3.727909,"eighty":-2.468814,"marketCap":44933209},{"date":"2025-10-24","current":-1.060422,"twenty":-5.516043,"median":-3.699343,"eighty":-2.388509,"marketCap":44933209},{"date":"2025-10-31","current":-1.075048,"twenty":-5.447334,"median":-3.691448,"eighty":-2.317303,"marketCap":45552977},{"date":"2025-11-07","current":-1.111614,"twenty":-5.371836,"median":-3.676368,"eighty":-2.244599,"marketCap":47102398},{"date":"2025-11-14","current":-0.828708,"twenty":-5.321912,"median":-3.651662,"eighty":-2.178806,"marketCap":42454135},{"date":"2025-11-21","current":-0.782205,"twenty":-5.233356,"median":-3.64221,"eighty":-2.124921,"marketCap":40071826},{"date":"2025-11-28","current":-0.819751,"twenty":-5.18765,"median":-3.621859,"eighty":-2.093402,"marketCap":41995273},{"date":"2025-12-05","current":-0.757174,"twenty":-5.110521,"median":-3.608617,"eighty":-2.055444,"marketCap":38789527},{"date":"2025-12-12","current":-0.719628,"twenty":-5.037066,"median":-3.577936,"eighty":-2.025264,"marketCap":36866080},{"date":"2025-12-19","current":-0.625701,"twenty":-4.9588,"median":-3.549105,"eighty":-1.981949,"marketCap":32054255},{"date":"2025-12-26","current":-0.522137,"twenty":-4.912548,"median":-3.544049,"eighty":-1.945365,"marketCap":26748745},{"date":"2026-01-02","current":-0.469135,"twenty":-4.89913,"median":-3.530125,"eighty":-1.880836,"marketCap":24033478},{"date":"2026-01-09","current":-0.657052,"twenty":-4.893905,"median":-3.501657,"eighty":-1.841207,"marketCap":33660334},{"date":"2026-01-16","current":-0.60236,"twenty":-4.863947,"median":-3.501004,"eighty":-1.780246,"marketCap":30858511},{"date":"2026-01-23","current":-0.657052,"twenty":-4.827714,"median":-3.463671,"eighty":-1.698098,"marketCap":33660334},{"date":"2026-01-30","current":-0.600733,"twenty":-4.820607,"median":-3.430485,"eighty":-1.632257,"marketCap":30775162},{"date":"2026-02-06","current":-0.500298,"twenty":-4.784865,"median":-3.387782,"eighty":-1.562303,"marketCap":25629940},{"date":"2026-02-13","current":-0.451176,"twenty":-4.684882,"median":-3.355987,"eighty":-1.389518,"marketCap":23113429},{"date":"2026-02-20","current":-0.488221,"twenty":-4.650603,"median":-3.310888,"eighty":-1.249103,"marketCap":25011231},{"date":"2026-02-27","current":-0.482464,"twenty":-4.611231,"median":-3.270848,"eighty":-1.139404,"marketCap":24716302},{"date":"2026-03-06","current":-0.461814,"twenty":-4.588626,"median":-3.232166,"eighty":-1.117465,"marketCap":23658406},{"date":"2026-03-13","current":-0.421973,"twenty":-4.584426,"median":-3.115445,"eighty":-1.099913,"marketCap":23598786},{"date":"2026-03-19","current":-0.4018,"twenty":-4.568894,"median":-3.077727,"eighty":-1.060422,"marketCap":22470583}],"updateTime":1774036266266},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SKYE\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608435001","title":"Skye Bioscience, Inc.盘中异动 早盘股价大涨7.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608435001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608435001?lang=zh_cn&edition=fundamental","pubTime":"2026-02-03 22:33","pubTimestamp":1770129201,"startTime":"0","endTime":"0","summary":"北京时间2026年02月03日22时33分，Skye Bioscience, Inc.股票出现异动，股价大幅拉升7.52%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Liminatus Pharma Inc C/Wts 30/04/2030 、阿诺医药、Caribou Biosciences, Inc.涨幅较大，Cdt Equity Inc.、Pmgc Holdings Inc.、Liminatus Pharma, Inc.较为活跃，换手率分别为607.48%、564.49%、42.37%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、阿诺医药、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为32.58%、13.48%、11.01%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣地亚哥的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203223322a6cef695&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203223322a6cef695&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SKYE"],"gpt_icon":0},{"id":"1167741515","title":"Skye公布Nimacimab联合司美格鲁肽Cbeyond二期a阶段扩展研究积极中期结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1167741515","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167741515?lang=zh_cn&edition=fundamental","pubTime":"2026-02-02 20:08","pubTimestamp":1770034126,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc.（简称“Skye”）近日披露了其创新药物Nimacimab与司美格鲁肽（Semaglutide）联合用药的Cbeyond二期a阶段扩展研究的中期分析数据，结果显示疗效积极。\n这项扩展研究旨在评估Nimacimab与司美格鲁肽联合治疗方案在特定患者群体中的长期安全性与有效性。中期数据表明，联合用药在关键疗效指标上表现出显著改善，且安全性和耐受性良好，未出现新的不良反应信号。\n研究结果的积极进展为Nimacimab的后续临床开发提供了有力支持，也为相关疾病领域的治疗带来了新的潜在选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"gpt_icon":0},{"id":"1106684585","title":"Skye Bioscience Inc. 联合疗法52周减重22.3%：Nimacimab联合司美格鲁肽（2.4毫克）展现显著成效","url":"https://stock-news.laohu8.com/highlight/detail?id=1106684585","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106684585?lang=zh_cn&edition=fundamental","pubTime":"2026-02-02 20:06","pubTimestamp":1770034013,"startTime":"0","endTime":"0","summary":"在为期52周的临床研究中，Skye Bioscience Inc. 所开发的Nimacimab与司美格鲁肽（2.4毫克）联合疗法取得了令人瞩目的成果，受试者体重平均下降幅度达到22.3%。这一数据凸显了该联合方案在体重管理领域的巨大潜力。\nNimacimab作为一种创新治疗成分，与已广泛应用的司美格鲁肽协同作用，显示出优于单一疗法的减重效果。研究结果不仅证实了联合用药的安全性，更为其在肥胖治疗领域的应用前景提供了有力支持。\n未来，Skye Bioscience Inc. 将继续推进相关临床研究，进一步探索该联合疗法的长期疗效与适用范围，为全球肥胖患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE"],"gpt_icon":0},{"id":"2601886640","title":"BUZZ-与 Halozyme 合作开发肥胖症药物，Skye 生物科学公司业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2601886640","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601886640?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 20:13","pubTimestamp":1767615231,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nL4T3Y60SJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HALO","SKYE","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"1158508067","title":"Skye Bioscience Inc.计划于2026年年中启动Nimacimab联合Enhanze技术治疗肥胖症的2B期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1158508067","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158508067?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 20:03","pubTimestamp":1767614583,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc.近日公布其研发战略，计划在2026年中期正式启动一项针对肥胖症治疗的2B期临床试验。该试验将重点评估其核心候选药物Nimacimab与奥洛兹美医疗（Halozyme Therapeutics）专有的Enhanze药物递送技术联合应用的疗效与安全性。\n这一临床进展标志着Skye在代谢疾病治疗领域迈出了关键一步。Nimacimab作为一种创新疗法，结合Enhanze技术旨在增强药物递送效率，有望为肥胖患者提供新的治疗选择。公司预计该试验将为后续临床开发提供重要数据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","SKYE","BK4139","HALO"],"gpt_icon":0},{"id":"1162485011","title":"奥洛兹美医疗与Skye Bioscience达成全球合作与许可协议，共同评估Nimacimab与Enhanze®复方制剂用于肥胖症治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1162485011","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162485011?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 20:02","pubTimestamp":1767614523,"startTime":"0","endTime":"0","summary":"奥洛兹美医疗与Skye Bioscience公司宣布，双方已签署一项全球性的合作与许可协议。该协议的核心内容是，将共同评估Nimacimab与奥洛兹美医疗的Enhanze®药物递送技术共同配制的复方制剂，用于治疗肥胖症的潜力。此次合作旨在结合两家公司的专长，探索这一创新疗法在代谢疾病领域的应用前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139","HALO","LU0053671581.USD"],"gpt_icon":0},{"id":"2595108746","title":"Skye Bioscience, Inc.盘中异动 股价大跌5.13%报0.740美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595108746","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595108746?lang=zh_cn&edition=fundamental","pubTime":"2025-12-30 22:32","pubTimestamp":1767105157,"startTime":"0","endTime":"0","summary":"北京时间2025年12月30日22时32分，Skye Bioscience, Inc.股票出现异动，股价急速跳水5.13%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Dermata Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Dermata Therapeutics, Inc.、Gri Bio, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为1408.00%、503.15%、30.62%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Dermata Therapeutics, Inc.、Coya Therapeutics, Inc.，振幅分别为20.95%、9.67%、9.01%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣地亚哥的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230223237a48ac17c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230223237a48ac17c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"gpt_icon":0},{"id":"2593649611","title":"Skye Bioscience, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593649611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593649611?lang=zh_cn&edition=fundamental","pubTime":"2025-12-22 23:05","pubTimestamp":1766415957,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日23时05分，Skye Bioscience, Inc.股票出现波动，股价急速下跌5.17%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、健永生技、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pmgc Holdings Inc.、Psyence Biomedical Ltd.、Gt Biopharma, Inc.较为活跃，换手率分别为121.62%、43.55%、17.08%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、健永生技、Equillium, Inc.，振幅分别为103.24%、59.29%、24.34%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣地亚哥的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222230557a6c203fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222230557a6c203fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SKYE"],"gpt_icon":0},{"id":"2588726807","title":"Skye Bioscience, Inc.盘中异动 快速下挫5.34%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588726807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588726807?lang=zh_cn&edition=fundamental","pubTime":"2025-12-01 23:26","pubTimestamp":1764602819,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日23时26分，Skye Bioscience, Inc.股票出现异动，股价大幅下挫5.34%。截至发稿，该股报1.24美元/股，成交量3.3126万股，换手率0.10%，振幅3.82%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣地亚哥的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012326599524ed5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012326599524ed5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"gpt_icon":0},{"id":"2583650580","title":"Skye Bioscience, Inc.盘中异动 早盘快速上涨6.85%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583650580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583650580?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 22:57","pubTimestamp":1762959450,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日22时57分，Skye Bioscience, Inc.股票出现异动，股价快速上涨6.85%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Leap Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Salarius Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为5706.48%、329.96%、221.30%，振幅较大的相关个股有Leap Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Salarius Pharmaceuticals, Inc.，振幅分别为60.41%、47.55%、43.88%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣地亚哥的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112225730950022a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112225730950022a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SKYE"],"gpt_icon":0},{"id":"2578542183","title":"Skye Bioscience, Inc.盘中异动 早盘股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578542183","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578542183?lang=zh_cn&edition=fundamental","pubTime":"2025-10-24 21:56","pubTimestamp":1761314215,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日21时56分，Skye Bioscience, Inc.股票出现异动，股价急速拉升5.52%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Genenta Science Spa、Neuphoria Therapeutics Inc.、Inhibrx Biosciences, Inc.涨幅较大，Neuphoria Therapeutics Inc.、Qualigen Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为2127.42%、1972.80%、1225.21%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Genenta Science Spa、Neuphoria Therapeutics Inc.，振幅分别为69.66%、66.25%、63.95%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣地亚哥的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024215655974093d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024215655974093d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"gpt_icon":0},{"id":"2577338488","title":"Skye Bioscience, Inc.盘中异动 早盘股价大涨5.26%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577338488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577338488?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 22:27","pubTimestamp":1761056869,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日22时27分，Skye Bioscience, Inc.股票出现异动，股价大幅拉升5.26%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.涨幅较大，Minerva Neurosciences, Inc、Ibio, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为1474.81%、202.88%、92.68%，振幅较大的相关个股有Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.，振幅分别为215.34%、88.41%、47.03%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣地亚哥的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021222749a46c8ff9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021222749a46c8ff9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SKYE"],"gpt_icon":0},{"id":"2573602573","title":"BUZZ-减肥药物中期研究未达主要目标，斯凯公司股价暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2573602573","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573602573?lang=zh_cn&edition=fundamental","pubTime":"2025-10-07 01:51","pubTimestamp":1759773094,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nL3T3VN10D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"gpt_icon":0},{"id":"2573679497","title":"斯凯生物科学公司的肥胖症药物未能达到中期研究的主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2573679497","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573679497?lang=zh_cn&edition=fundamental","pubTime":"2025-10-06 19:08","pubTimestamp":1759748907,"startTime":"0","endTime":"0","summary":"斯凯生物科学公司的肥胖症药物未能达到中期研究的主要目标路透社10月6日 - 斯凯生物科学公司（Skye Bioscience SKYE.O）周一表示，其实验性肥胖症药物没有达到一项中期 研究的主要目标。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nL3T3VN0JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"gpt_icon":0},{"id":"1190434312","title":"Skye Bioscience公布Cbeyond™ 2a期临床试验顶级数据，涵盖Nimacimab单药治疗和联合治疗方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1190434312","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190434312?lang=zh_cn&edition=fundamental","pubTime":"2025-10-06 19:02","pubTimestamp":1759748553,"startTime":"0","endTime":"0","summary":"Skye Bioscience发布了其Cbeyond™ 2a期临床试验的主要数据结果，该试验评估了Nimacimab单药治疗和联合治疗方案的疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"gpt_icon":0},{"id":"2571934427","title":"BUZZ-H.C. Wainwright 给予 Skye Bioscience \"买入 \"评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2571934427","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571934427?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 19:48","pubTimestamp":1759232882,"startTime":"0","endTime":"0","summary":"BUZZ-H.C. Wainwright 给予 Skye Bioscience \"买入 \"评级9月30日 - ** 券商H.C. Wainwright给予Skye Bioscience SKYE.O\"买入 \"评级，看好Skye减肥药的安全性和持久性。** H.C. Wainwright 表示：\"很大程度上缓冲了下跌空间，小幅利好数据可能会提振股价，强劲的结果使 nimacimab 成为主要的肥胖症辅助药物\"。** 覆盖该公司股票的七位分析师都给予了 \"买入 \"或更高的评级；PT 中位数为 14.50 美元--LSEG 数据** 截至上一交易日收盘，SKYE股价年累计上涨37.1%。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nL3T3VH0V5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}